Previous work demonstrated that Tgfbr2F/F;Nkx2.1-cre mice are protected from lung disease caused by transgenic overexpression of TGFβ1 or neonatal hyperoxia treatment (Sureshbabu et al., 2015). Here, TGFB1 is linked to lung disorder.